Annick Desjardins

15.7k citations
247 papers · 10.0k indexed · 4 hit papers · h-index 51

Annick Desjardins

228 papers receiving 9.8k citations

Hit Papers

Recurrent Glioblastoma Treated with...58220072026201320192505007501000

Peers

Annick Desjardins
Comparison fields: 5 of 125
  • Genetics 6.3k
  • Cancer Research 2.2k
  • Oncology 2.6k
  • Neurology 1.3k
  • Pulmonary and Respiratory Medicine 2.2k
Replace Peter Hau with:
Peter Hau Germany
Howard Colman United States
Ryo Nishikawa Japan
Burt Nabors United States
W.K. Alfred Yung United States
Erik P. Sulman United States
Marie‐France Hamou Switzerland
Ian F. Parney United States
Marc Sanson France
Daniel P. Cahill United States
Annick Desjardins relative to Peter Hau Germany Peter Hau's profile →
Citations per field
00.5×1.5×
Peter Hau · 1×
Citations per year

Countries citing papers authored by Annick Desjardins

Since Specialization
Citations

This map shows the geographic impact of Annick Desjardins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Desjardins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Desjardins more than expected).

Fields of papers citing papers by Annick Desjardins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Desjardins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Desjardins. The network helps show where Annick Desjardins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Annick Desjardins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Annick Desjardins Line = papers co-authored together Annick Desjardins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20244
3 20234
4 202311
5 20213
6 202115
7 20195
8 201911
9 201912
10 20198
11 20174
12 201291
13 201194
14 2011112
15 201169
16 201140
17 200969
18 2008130
19 200839
20 2007250

About Annick Desjardins

Annick Desjardins is a scholar working on Genetics, Biotechnology and Oncology, having authored 247 papers that have together received 10.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (173 papers), Brain Metastases and Treatment (59 papers), Cancer Research and Treatments (31 papers), Cancer, Hypoxia, and Metabolism (31 papers), Cancer Treatment and Pharmacology (29 papers), Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (17 papers) and Virus-based gene therapy research (16 papers). The work is most often cited by research in Genetics (6.3k citations), Cancer Research (2.2k citations) and Oncology (2.6k citations). Annick Desjardins has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Henry S. Friedman, James J. Vredenburgh, David A. Reardon, James E. Herndon, Allan H. Friedman, John H. Sampson, Jeremy N. Rich, Darell D. Bigner, Sridharan Gururangan and Jennifer A. Quinn. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026